Brief: Theradiag Reports FY Operating Loss Of 0.6 Million Euros

Theradiag SA

22/03/2021 06:52

March 22 (Reuters) - Theradiag SA  ALTHE.PA :
    * FY REVENUE 10.4 MILLION EUR
    * FY REVENUE GROWTH OF 8.0%, DRIVEN BY EXCELLENT PERFORMANCE
OF
THERANOSTICS
    * SUBSTANTIAL IMPROVEMENT OF 44.5% IN FY NET RESULT BEFORE
NON-RECURRING ITEMS
    * END-FY SOLID CASH POSITION AT € 3.5M
    * FY OPERATING LOSS EUR 0.6 MILLION VERSUS LOSS OF EUR 0.6
MILLION
YEAR AGO
    * RESEARCH AND DEVELOPMENT INVESTMENTS AND DEVELOPMENT
INVESTMENTS
IN THE UNITED STATES MAINTAINED TO SUPPORT FUTURE GROWTH
    * FY LOSS BEFORE TAX EUR 0.6 MILLION VERSUS LOSS OF EUR 0.6
MILLION YEAR AGO
    * RESEARCH AND DEVELOPMENT INVESTMENTS AND DEVELOPMENT
INVESTMENTS
IN THE UNITED STATES MAINTAINED TO SUPPORT FUTURE GROWTH; CO TO
MAINTAIN THESE INVESTMENTS IN 2021

Source text for Eikon:  ID:nBw3clgYma 
Further company coverage:  ALTHE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))